BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16613540)

  • 21. Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis.
    Casanovas O; Hager JH; Chun MG; Hanahan D
    Oncogene; 2005 Oct; 24(44):6597-604. PubMed ID: 16007165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and evaluation of dual CDK1 and CDK2 inhibitors.
    Payton M; Chung G; Yakowec P; Wong A; Powers D; Xiong L; Zhang N; Leal J; Bush TL; Santora V; Askew B; Tasker A; Radinsky R; Kendall R; Coats S
    Cancer Res; 2006 Apr; 66(8):4299-308. PubMed ID: 16618755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
    Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
    Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways.
    Kim JA; Hong S; Lee B; Hong JW; Kwak JY; Cho S; Kim CC
    Cell Immunol; 2007 Jan; 245(1):16-23. PubMed ID: 17470365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors.
    Li AF; Li AC; Tsay SH; Li WY; Liang WY; Chen JY
    Am J Clin Pathol; 2008 Oct; 130(4):535-42. PubMed ID: 18794045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p300 is required for orderly G1/S transition in human cancer cells.
    Iyer NG; Xian J; Chin SF; Bannister AJ; Daigo Y; Aparicio S; Kouzarides T; Caldas C
    Oncogene; 2007 Jan; 26(1):21-9. PubMed ID: 16878158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
    Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
    Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest.
    Cui Y; Lu C; Liu L; Sun D; Yao N; Tan S; Bai S; Ma X
    Life Sci; 2008 Jan; 82(5-6):247-55. PubMed ID: 18164318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoblastoma deficiency increases chemosensitivity in lung cancer.
    Zagorski WA; Knudsen ES; Reed MF
    Cancer Res; 2007 Sep; 67(17):8264-73. PubMed ID: 17804741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
    Enomoto K; Mimura T; Harris DL; Joyce NC
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts.
    Gao A; Liu B; Shi X; Jia X; Ye M; Jiao S; You B; Huang C
    Toxicol Lett; 2007 Apr; 170(1):30-41. PubMed ID: 17383120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of gene expression profile of G1/S transition in gastric cancer cell cycle].
    Lan B; Liu BY; Zhang J; Wang KK; Chen XH; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):229-33. PubMed ID: 16167235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
    Osada H; Takahashi T
    Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16INK4A participates in a G1 arrest checkpoint in response to DNA damage.
    Shapiro GI; Edwards CD; Ewen ME; Rollins BJ
    Mol Cell Biol; 1998 Jan; 18(1):378-87. PubMed ID: 9418885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synergistic effect of the expression of p16INK4 gene and retinoblastoma gene in lung cancer].
    Cao XR; Zhang XR; Su CQ
    Yi Chuan Xue Bao; 2001; 28(7):601-5. PubMed ID: 11480170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis for G1 cell-cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer.
    Michalides R
    J Pathol; 1999 Aug; 188(4):341-3. PubMed ID: 10440742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression.
    Braden WA; Lenihan JM; Lan Z; Luce KS; Zagorski W; Bosco E; Reed MF; Cook JG; Knudsen ES
    Mol Cell Biol; 2006 Oct; 26(20):7667-81. PubMed ID: 16908528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The RB gene family and control of the cell cycle].
    Sage J
    Bull Cancer; 2001 Jun; 88(6):541-3. PubMed ID: 11459699
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer.
    Marchetti A; Doglioni C; Barbareschi M; Buttitta F; Pellegrini S; Gaeta P; La Rocca R; Merlo G; Chella A; Angeletti CA; Dalla Palma P; Bevilacqua G
    Int J Cancer; 1998 Jan; 75(2):187-92. PubMed ID: 9462706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.